Key result
Diabetes in elderly patients is linked to a ~66% higher risk of failed streptokinase thrombolysis.
Why the study?
Age and diabetes are key prognostic factors in STEMI patients undergoing thrombolysis, leading investigators to compare the post-thrombolytic efficacy of streptokinase between elderly diabetic and non-diabetic patients.
Does streptokinase have different thrombolytic efficacy in elderly diabetic versus non-diabetic patients with STEMI?
Observational (n=140)
No
Does streptokinase have different thrombolytic efficacy in elderly diabetic versus non-diabetic patients with STEMI?
Elderly diabetic patients with STEMI have significantly higher rates of failed thrombolysis with streptokinase compared to non-diabetics, suggesting alternative reperfusion strategies may be needed.
Answers are grounded in this paper and cite their sources.
Failed thrombolysis with streptokinase was associated with diabetes in elderly STEMI; hypothesis-generating for differential efficacy and alternative reperfusion pending randomized trials.
Background: Age and diabetes are important prognostic factors in patients with acute ST-elevation myocardial infarction (STEMI) undergoing thrombolysis. In our study we compared the post-thrombolytic effect of streptokinase in elderly diabetic and non-diabetic patients. Methods: A prospective observational study was conducted in tertiary care center of India in which 140 elderly patients diagnosed with STEMI and undergoing thrombolytic therapy with streptokinase were enrolled after making necessary exclusions and were divided into diabetic (n=70) and non-diabetic (n=70) as study and control groups respectively. ECG was done immediately before and at 60 minutes after thrombolytic therapy. ST-segment resolution was measured and patients were classied as failed (<30%), partial (30-70%) and successful (>70%) resolution of STsegment. Results: Failed thrombolysis was evident in 34.3% non-diabetic and 57.1% diabetic patients (p=0.010). The incidence of successful thrombolysis was present in 41.4% non-diabetic and 28.6% diabetic patients, whereas partial thrombolysis was seen in 24.3% non-diabetic and 14.3% diabetics. Anterior wall was the most common location of infarction in elderly population but the proportion was higher in diabetics than non-diabetics (p=0.025). Conclusion: Failed thrombolysis with streptokinase was higher in diabetics than in non-diabetics after 60 minutes of streptokinase infusion in elderly patients warranting the need of using another cost effective and easily available agent for elderly diabetic population.
No takes yet. Share an insight, caveat, or question.
Pratap et al. (2021) conducted an observational in acute ST-elevation myocardial infarction (STEMI) (n=140). Streptokinase in diabetic patients vs. Streptokinase in non-diabetic patients was evaluated on Failed thrombolysis (<30% ST-segment resolution) (p=0.010). Failed thrombolysis with streptokinase was significantly higher in elderly diabetic patients compared to non-diabetics (57.1% vs 34.3%, p=0.010) at 60 minutes post-infusion.
Synapse has enriched 10 related papers. Consider them for comparative context: